Egyptian Drug Authority Chair Discusses Hikma Investment
The Egyptian Drug Authority held a meeting with Hikma to discuss domestic manufacturing of medicines in Egypt, as well as enhancing production and export capabilities. The two parties emphasized the importance of expanding investments and improving the quality of local pharmaceutical products, while reviewing localization projects and continuous development of factories. The purpose of the meeting is to support the Egyptian government's plan to deepen local manufacturing, increase the pharmaceutical industry's competitiveness internationally, and secure a steady supply of medicines for Egyptian patients.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)